Association between use of oral hypoglycemic agents in Japanese patients with type 2 diabetes mellitus and risk of depression: A retrospective cohort study

Abstract Type 2 diabetes mellitus (T2DM) is a risk factor for depression. Since brain insulin resistance plays a potential role in depression, the future risk of depression in patients with T2DM may be altered depending on the class of oral hypoglycemic agent (OHA) used for T2DM therapy. The aim of...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Hayato Akimoto, Kotoe Tezuka, Yayoi Nishida, Tomohiro Nakayama, Yasuo Takahashi, Satoshi Asai
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2019-12-01
coleção:	Pharmacology Research & Perspectives
Assuntos:	depression dipeptidyl peptidase‐4 inhibitor oral hypoglycemic agent type 2 diabetes mellitus
Acesso em linha:	https://doi.org/10.1002/prp2.536
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!